A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Phase of Trial: Phase II
Latest Information Update: 17 May 2017
At a glance
- Drugs ADX 102 (Primary)
- Indications Anterior uveitis
- Focus Therapeutic Use
- Sponsors Aldeyra Therapeutics
- 17 May 2017 According to an Aldeyra Therapeutics media release, data was presented at the Association for Research in Vision and Ophthalmology (ARVO) 2017 Annual Meeting.
- 18 May 2016 Status changed from active, no longer recruiting to completed.
- 09 May 2016 Results published in an Aldeyra Therapeutics media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History